drugset / Trial / NCT00334399

Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide

NCT00334399

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus treated with Biguanide.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Miglitol Small molecule